Will surgical caps make a comeback in the OR? A shift in may be on the horizon.
"I came to realize that it's our ability to elicit people's priorities that ultimately matters," Atul Gawande, MD, said in a recent on becoming a good surgeon.
A recent has found that using Kadcyla, in lieu of Herceptin, to treat HER2-positive early breast cancer after neoadjuvant chemotherapy improves invasive disease-free survival.
The current state of in the U.S. "doesn't cut it anymore," surgeons say.
A new designed for patients to use at home may help prevent deep vein thrombosis and pulmonary embolism after surgery.
General Surgery News Report is brought to 鶹ý readers by our friends at , a title. Registration (free) may be required for some content.